Flipped script for gefitinib: A reapproved tyrosine kinase inhibitor for first-line treatment of epidermal growth factor receptor mutation positive metastatic nonsmall cell lung cancer.
about
Mechanisms of drug resistance in colon cancer and its therapeutic strategiesHistopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumorsTargeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors.Brain metastasis in non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations: a report of seven cases and literature review.The economic case for precision medicine.
P2860
Flipped script for gefitinib: A reapproved tyrosine kinase inhibitor for first-line treatment of epidermal growth factor receptor mutation positive metastatic nonsmall cell lung cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Flipped script for gefitinib: ...... tic nonsmall cell lung cancer.
@en
Flipped script for gefitinib: ...... tic nonsmall cell lung cancer.
@nl
type
label
Flipped script for gefitinib: ...... tic nonsmall cell lung cancer.
@en
Flipped script for gefitinib: ...... tic nonsmall cell lung cancer.
@nl
prefLabel
Flipped script for gefitinib: ...... tic nonsmall cell lung cancer.
@en
Flipped script for gefitinib: ...... tic nonsmall cell lung cancer.
@nl
P2093
P2860
P356
P1476
Flipped script for gefitinib: ...... tic nonsmall cell lung cancer.
@en
P2093
Brian S Bogdanowicz
Matthew A Hoch
Megan E Hartranft
P2860
P304
P356
10.1177/1078155216634179
P577
2016-07-08T00:00:00Z